Chronic obstructive pulmonary disease (COPD) is a disease state characterized by chronic airtlow limitation that is not fully reversible, with a precise definition varying between different management guidelines.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a disease state characterized by airflow limitation that is not fully reversible.The airtlow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to inhalation of noxious particles or gases (I). However, COPD is not a disease that can be readily diagnosed since airflow limitation must be measured using spirometry. Diagnosis of COPD is further complicated by the discrepancy frequently observed between symptoms and the degree of airflow limitation, and by the need to differentiate from asthma.
The lung function definition of airflow limitation in COPD varies according to different guidelines (Table I) . These factors complicate the study of COPD epidemiology, as well as the assessment of the burden of the disease. This paper examines the burden of COPD from the perspective of society, the patient, the physician managing the disease, and the healthcare payer.Although the burden is considerable from all these perspectives, attitudes towards the disease seem to prevent appropriate actions being taken to address the problems caused.The attitudes contributing to lack of appreciation of the impact of COPD are also considered, together with future actions that could be taken to address these issues. Although in 1990 COPD was ranked sixth in the list of mortality causes worldwide, it is expected to reach third place by 2020 (6) . In the U.S.A., the age-adjusted death rate for COPD rose between 1965 and 1998, while it fell for coronary heart disease, stroke and other cardiovascular diseases ( Fig. 2 ) (l,7). In the U.S.A., COPD is now the fourth leading cause of death (behind heart disease, cancer and cerebrovascular disease). Even though COPD is mainly a disease affecting elderly people, there is still a high potential for loss of life-years.
Analysis of data from the Flemish regional registration agency in Belgium showed that COPD accounted for more life-years lost among males aged l-74 years than heart failure (8, 9) .
Society has to bear the economic impact of COPD, which covers the direct medical costs (considered in more detail below) and the indirect costs arising from the need for disability and pension payments, the consequences of sick leave from employment and the losses arising from early mortality. 
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A number of inter-linked factors can be identified that contribute to the poor recognition of the burden of COPD.
Poor recognition
Patients fail to recognize the early symptoms of COPD.
Symptoms may be attributed to smoking itself, rather than to the early stages of a specific medical condition.
This means that they do not present for diagnosis, and fail to receive a medical label for the symptoms they experience. It would be interesting to investigate the relative success of smoking interventions in people during early middle age given a medical diagnosis, compared with those who do not receive a medical label. It could be postulated that the patients given early warning of their condition may take more active steps to stop smoking, in the same way that many patients who suffer an early heart attack make drastic changes to their lifestyle. 
Difficulties in diagnosis
